SSA
BMY icon

Schonfeld Strategic Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100,000
Closed -$232K – 765
2017
Q4 		$232K Buy
+100,000
New +$6.25M 0.02% 639

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's BMY Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Bristol-Myers Squibb (BMY) stake by 62% in Q1 2026, selling an estimated $14.7M and leaving 155,418 shares worth $9.11M. The position accounts for 0.06% of the portfolio, ranked #325.

Schonfeld Strategic Advisors first reported a position in BMY in Q1 2016 and has held it in 36 quarters since. The position peaked at $52.9M in Q3 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Schonfeld Strategic Advisors held 155,418 shares of Bristol-Myers Squibb worth $9.11M as of Q1 2026.
  • Schonfeld Strategic Advisors sold 252,821 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.7M.
  • Bristol-Myers Squibb made up 0.06% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #325 holding.
  • Schonfeld Strategic Advisors first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 36 quarters since.
  • Schonfeld Strategic Advisors's Bristol-Myers Squibb position peaked at $52.9M in Q3 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.